SHANGHAI JINDUN INDUSTRIAL CO.,LTD

About SHANGHAI JINDUN INDUSTRIAL CO.,LTD

JIN DUN Medical Research lnstitute is affiliated to Shghai JINDUN Industrial Co., Ltd., headquartered in Shanghai. adiacent tHongqiao High-speed Railway Station and Hongqiao Internationl airport. JIN DUN Medical Research Institute is committed toproviding pharmaceutical intermediates and raw materials withthe purpose of innovative drug researchCustomized R&D anccustomized production services.

  • CN
  • 2023
    On CPHI since
  • 100 - 249
    Employees
Company types
Distributor/Import Export
Contact info
  • No.9, Lane 3599, Qixin road, Minhang district, Shanghai, China, 201100, Shanghai, China
Meet us at

CPHI & PMEC China 2024

Shanghai New International Expo Center
19 - 21 June 2024

Products from SHANGHAI JINDUN INDUSTRIAL CO.,LTD (5)

  • Empagliflozin

    Product Empagliflozin

    Basic InfoGrade: Pharmaceutical Grade Factory Location: China Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa Sample Provided: yes Payment Terms: L/C Product Name: Empagliflozin Cas No.:&nbs...
  • Linagliptin

    Product Linagliptin

    产品名:利格列汀 CAS 编号: 668270-12-0 分子式: C25H28N8O2 分子式: 472.54 EINECS编号: 1308068-626-2 熔点:202 ºC 沸点:661.2±65.0°C(预测) 密度:1.39 应用:抗糖尿病

  • Nifedipine

    Product Nifedipine

    Long-term coronary vasodilators. This product can increase coronary blood flow, reducing myocardial oxygen consumption.it is used for acute and chronic coronary insufficiency,especially the angina and myocardial infarction.
  • Sitagliptin phosphate monohydrate

    Product Sitagliptin phosphate monohydrate

    sitagliptin phosphate monohydrate is the phosphate salt of its active component, sitagliptin, with one molecule of water. sitagliptin is a potent inhibitor of dipeptidyl peptidase 4 (dpp-4), an enzyme catalyzing the cleavage of peptides with an n-terminal alanine or proline amino acid residue, that selecti...
  • Valsartan

    Product Valsartan

    Valsartan is a type of specific angiotensin I (AT1) receptor antagonist and a clinical non-dermal AT1 receptor antagonist following losartan that has important effects in adjusting bodily blood pressure and maintaining electrolyte-body fluid balance. Valsartan’s antihypertensive effects are stronger than t...